Testing version — LOERadar is in active testing. Features and data may change.
LUMIGAN (BIMATOPROST) | LOERadar
LUMIGAN
NDA
BIMATOPROST | N021275 | ABBVIE INC
1 strength0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 0.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▴
SOLUTION/DROPS;OPHTHALMIC | Approved: Mar 16, 2001
No patent or exclusivity listings for this strength.